Day: January 21, 2020

SEATTLE, Jan. 21, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the commencement of a proposed underwritten public offering of 8,000,000 shares of its common stock by certain selling shareholders. In addition, certain selling shareholders expect to grant the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of its common stock in the offering. Adaptive will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling shareholders. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering...

WEST PALM BEACH, Fla., Jan. 21, 2020 (GLOBE NEWSWIRE) — Fifth Street Asset Management Inc. (OTCPK:FSAM) (“FSAM” or the “Company”) today announced that on January 21, 2020 its Board of Directors declared a cash distribution of $1.18 per share and a distribution in kind of 0.06783 shares of Oaktree Specialty Lending Corporation (NASDAQ:OCSL) per share, in both cases payable on January 30, 2020 to stockholders of record of FSAM Class A Common Stock as of January 21, 2020. NASD UPC (Uniform Practice Code) rule 11140 provides that, in respect to dividends or distributions that are 25 percent or greater of the value of the subject security, the ex-dividend date shall be the first business day following the payable date. Accordingly, an FSAM investor that sells shares of FSAM common stock prior to the payment...

SHANGHAI, China, and SAN FRANCISCO, Jan. 21, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of 5,500,000 American depositary shares (“ADSs”), each representing one ordinary share of the Company (the “Primary ADS Offering”). In addition, QM11 Limited, a shareholder of the Company, intends to offer 500,000 ADSs of the Company (the “Secondary ADS Offering” and together with the Primary ADS Offering, the “Offering”). Zai Lab and QM11 Limited expect to grant the underwriters a 30-day option to purchase up to 800,000 and 100,000 additional ADSs, respectively. Zai Lab will not receive...

NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of 1,750,000 shares of its common stock, par value $0.0001 per share, in an underwritten registered public offering. The Company expects to grant the underwriters a 30-day option to purchase up to 262,500 additional shares of common stock.The Company intends to use the net proceeds from this offering, together with its existing cash and cash equivalents, to advance AT-007 for the treatment of Galactosemia including pre-launch activities and preparing for a potential commercial launch, to fund clinical...

HOUSTON, Jan. 21, 2020 (GLOBE NEWSWIRE) — TC PipeLines, LP (NYSE: TCP) (the Partnership) today announced that the board of directors of TC PipeLines GP, Inc., its general partner, declared the Partnership’s fourth quarter 2019 cash distribution of $0.65 per common unit. The distribution is unchanged from the distributions declared for the previous three quarters of 2019.This cash distribution is the 83rd consecutive quarterly distribution paid by the Partnership and is payable on February 14, 2020 to unitholders of record at the close of business on January 31, 2020.About TC PipeLines, LPTC PipeLines, LP is a Delaware master limited partnership with interests in eight federally regulated U.S. interstate natural gas pipelines which serve markets in the Western, Midwestern and Northeastern United States. The Partnership is managed...

VANCOUVER, British Columbia, Jan. 21, 2020 (GLOBE NEWSWIRE) — Avrupa Minerals Ltd. (AVU:TSXV) is pleased to provide a corporate update and corresponding goals for the coming year.  The Company enters 2020 with the pending startup of work on the flagship Alvalade Joint Venture Project, along with partner, Spanish miner Minas de Aguas Teñidas, SA (MATSA).  Startup will occur upon issuance of a new Alvalade Experimental Exploitation License (EEL) in accordance with the present mining law of Portugal.  The Mining Bureau has verified that Avrupa’s subsidiary in Portugal has fulfilled all obligations for the EEL application and over the next 30 working days will complete the collection of final social and technical due diligence data for the Alvalade license area.During 2020, the Company also plans to continue...

NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, issued the following letter to shareholders:January 21, 2020To our shareholders:On behalf of the Board of Directors, we are pleased to provide you with this update on our activities since you elected five new independent directors to the Company’s Board. With your clear mandate, we immediately took action to independently evaluate the business and prospects of Progenics, including the transaction with Lantheus Holdings, Inc. and to ensure that there is no interruption in the execution of the Company’s mission of developing and marketing products that improve outcomes for patients with...

WILMINGTON, Del., Jan. 21, 2020 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in education loan management and business processing solutions, today posted its 2019 fourth-quarter and full-year financial results. The complete financial results release is available on the company’s website at Navient.com/investors.The results will also be available on Form 8-K on the SEC’s website at www.sec.gov.Navient will hold a conference call tomorrow, Jan. 22, 2020 at 8 a.m. ET, hosted by Jack Remondi, president and CEO, and Chris Lown, CFO.To access the conference call, dial 855-838-4156 (USA and Canada) or 267-751-3600 (international) and use access code 5498068 starting at 7:45 a.m. ET. The live audio webcast will be available on Navient.com/investors. Supplemental financial information and presentation slides used during...

SAN JOSE, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of power-efficient visual processing solutions, will release its fourth quarter and fiscal 2019 financial results on February 6, 2020 after market close. Todd DeBonis, President and CEO, and Elias Nader, CFO, will host a conference call at 2:00 p.m. Pacific Time to discuss the Company’s financial results.Analysts and investors are invited to join the Company’s conference call using the following information:Date: Thursday, February 6, 2020Time: 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)Conference Call Number: 1-877-359-9508International Call Number: +1-224-357-2393Conference ID: 6816609Additionally, a live audio webcast of the conference call will be available and archived for approximately 90 days in the Investors...